Introduction
============

In China, laryngeal squamous cell carcinoma (SCC) accounts for \~7.9--35% of all the head and neck malignant tumors, and \~1.2--1.6% of all malignant tumors ([@b1-etm-06-05-1137]). The induction and development of tumors involves multiple factors ([@b2-etm-06-05-1137]). As the tumor grows larger than 1 × 1 × 2 mm, its further expansion relies on the growth of new inner blood vessels, which is subject to the modulation of various cytokines. Angiopoietin (Ang) and its receptor Tie-2 are the two key cytokines regulating the development of tumor blood vessels ([@b3-etm-06-05-1137]). The positive rate of Ang-2 expression in laryngeal SCC is significantly higher than in normal mucosa tissue. As the differentiation decreased, the expression of Ang-2 increased The overexpression of Ang-2 contributes to the occurrence of laryngeal SCC. It appears that laryngeal SCC is associated with the expression of Ang-2. Previous studies show that cyclin D1 is not or seldom expressed in the normal tissue, but it is highly expressed in numerous malignant tumors. Cyclin D1 is associated with the tumor classification and may be regarded as a potential prognostic indicator. The aim of this study is to investigate the expression of Ang-2 and cyclin D1 in the laryngeal SCC and clinicopathological signification. It is likely that they play a significant role in tumor induction, development and metastasis ([@b4-etm-06-05-1137]).

Materials and methods
=====================

Materials
---------

A total of 116 laryngeal SCC specimens were collected between January 2003 and December 2011 from The Otolaryngology Department of The Affiliated Hospital of Nantong University (Nantong, China). The complete clinical and pathological materials were well preserved. Of these patients, there were 107 males and 9 females aged from 42 to 83 years, with an average age of 62.8 years. According to the standard classification of head and neck neoplasm histopathology listed by the WHO (World Health Organization) ([@b5-etm-06-05-1137]) in 2005, 60 cases were well differentiated, 45 moderately differentiated and 11 poorly differentiated. The patients studied were initial cases without radiotherapy, chemotherapy or biotherapy before surgery. In addition, five cases of vocal cord polyp and five cases of atypical hyperplasia were used as control groups. We tracked the survival condition of 116 cases following surgery and recorded the causes of mortality in patients. For example, certain individuals succumbed to tumor, accident or other causes. The calculation of overall survival (OS) starts from the established diagnosis to the mortality caused by the tumor or the termination of follow-up study. Any mortality irrelevant to laryngeal SCC was recorded as truncation. This study was approved by the Ethics Committee of Affiliated Hospital of Nantong University, Nantong, China). Written informed consent was obtained from all patients.

Specimen preparation
--------------------

Fresh tissues were fixed with 4% paraformaldehyde, embedded with paraffin, cut into serial sections with a thickness of 4 *μ*m and stained with hematoxylin and eosin and Ang-2 and cyclin D1 immunohistochemical stains.

Immunohistochemical staining
----------------------------

Paraffin sections were deparaffinized, dehydrated and antigen retrieval was conducted by microwave for 15 min within citrate buffer solution (pH 6.0). Droplets of polyclonal rabbit anti-human Ang-2 and cyclin D1 were distributed into the deparaffinized sections for streptavidin-perosidase (S-P) staining. The known positive section was used as a positive control, normal goat serum as a negative control in place of primary antibody and PBS as a blank control also in place of primary antibody.

Immunohistochemical scoring
---------------------------

Ang-2 was located in the cytoplasm of tumor cells. Positive staining is observed as bright yellow, brown yellow or brown granules focally or diffusively distributed. Cyclin D1 was located in the tumor cell nucleus. Cyclin D1 protein expression is indicated by bright yellow, brown yellow or brown granules focally or diffusively distributed. Semi-quantitative results were obtained under a microscope (Olympus BX51-P; Olympus, Tokyo, Japan) using the method of Xu and Yang ([@b6-etm-06-05-1137]), which is dependent on the staining intensity and number of positive cells. Standard scores of staining intensity were as follows: no staining, 0 points; bright yellow, 1 point; brown yellow, 2 points; brown, 3 points. Number of positive cells under the same objective: negative, 0; number of stained cells within one field of vision ≤10%, 1 point; 11--50%, 2 points; 51--75%, 3 points; ≥76%, 4 points. The result of the two scores multiplied was graded: 0--2 as (-); 3 as (+); 4 as (++); ≥5 as (+++); results between + and +++ indicate to presence of expression.

Statistical analysis
--------------------

SPSS 17.0 (SPSS, Inc., Chicago, IL, USA) was employed to statistically process the relevant data. The χ^2^ test was used to compare the expression of Ang-2 and cyclin D1 in each group. The correlation comparison between Ang-2 and cyclin D1 was calculated using the Spearman's rank correlation analysis. P\<0.05 was considered to indicate a statistically significant result.

Results
=======

Expression of Ang-2 in vocal cord polyp, atypical hyperplasia and laryngeal SCC tissues
---------------------------------------------------------------------------------------

The positive rate of Ang-2 was 0% (0/5) in vocal cord polyp and 0% (0/5) in atypical hyperplasia. The positive rate in laryngeal SCC tissues was 40% for well differentiated, 66.7% for moderately differentiated and 100% for poorly differentiated. The positive staining located in the cytoplasm was as bright yellow, brown yellow or brown granules focally or diffusively distributed ([Figs. 1](#f1-etm-06-05-1137){ref-type="fig"}--[3](#f3-etm-06-05-1137){ref-type="fig"}). Ang-2 expression presented as brown staining in the vascular endothelial cells ([Fig. 4](#f4-etm-06-05-1137){ref-type="fig"}). one group from the groups of the vocal cord polyp and atypical hyperplasia and one group from the groups of well, moderately and poorly differentiated laryngeal SCC, statistical significance was indicated (P\<0.05). A pairwise comparison was conducted among the well, moderately and poorly differentiated laryngeal SCC groups (P\<0.05; [Table I](#t1-etm-06-05-1137){ref-type="table"}).

Expression of cyclin D1 in vocal cord polyp, atypical hyperplasia and laryngeal SCC tissues
-------------------------------------------------------------------------------------------

The incidence of cyclin D1 expression was 0% (0/5) in vocal cord polyp and 0% (0/5) in atypical hyperplasia. As for its positive rate in laryngeal SCC tissues, it was 50% for well differentiated, 66.7% for moderately differentiated and 100% for poorly differentiated laryngeal SCC. The positive staining was located in the nucleus as bright yellow, brown yellow or brown granules ([Figs. 5](#f5-etm-06-05-1137){ref-type="fig"}--[7](#f7-etm-06-05-1137){ref-type="fig"}). The staining was focally positive and infiltrated into the lymph gland ([Fig. 8](#f8-etm-06-05-1137){ref-type="fig"}). The interclass differences between the well, moderately and poorly differentiated laryngeal SCC groups and the vocal cord polyp and atypical hyperplasia groups was statistically significant (P\<0.05). Interclass expressions for the well and moderately differentiated groups and the well and poorly differentiated groups were statistically significant (P\<0.05). No statistical significance was identified between the moderately and poorly differentiated groups ([Table II](#t2-etm-06-05-1137){ref-type="table"}).

Association between Ang-2 expression in laryngeal SCC and clinically pathological factors
-----------------------------------------------------------------------------------------

The proportions of positive staining of Ang-2 in the well, moderately and poorly differentiated laryngeal SCC groups were 40, 66.7 and 100%, respectively. Differences exist among the three groups, for example, the poorly differentiated group showed an expression rate higher than those of the well and moderately differentiated groups. The interclass difference was statistically significant (Z=4.020; P\<0.05). The proportions of positive staining of laryngeal SCC in TNM grades T1+T2 and T3+T4 were 46.7 and 73.2%, respectively. The positive rate of Ang-2 increases at later pathological stages. The Ang-2 expression of advanced laryngeal SCC is higher than that of early-stage cancer (Z=−3.006, P\<0.05). The positive rate of lymph-metastasis group and that of non-lymph-metastasis group was 82.1 and 47.7%, respectively, the expression difference was statistically significant (Z=−4.129, P\<0.05). The proportions of positive staining of the smoking group and that of the non-smoking group were 67.6 and 39.6%, respectively, the expression difference was significantly different (Z=−3.190, P\<0.05).

Differences in Ang-2 expression according to gender, age, primary tumor site or drinking habits were not statistically significant ([Table III](#t3-etm-06-05-1137){ref-type="table"}).

Association between cyclin D1 expression and laryngeal SCC clinical pathological factors
----------------------------------------------------------------------------------------

The proportions of positive staining of cyclin D1 in the well, moderately and poorly differentiated laryngeal SCC group tissues were 50, 66.7 and 100%, respectively. Interclass comparisons of the expression in the well and moderately differentiated groups and well and poorly differentiated groups were statistically significant (Z=−2.814, P\<0.05 and Z=−4.087, P\<0.05). No statistically significant difference of expression was observed between the moderately and poorly differentiated groups. The proportions of positive staining of laryngeal SCC in the T1+T2 and T3+T4 TNM stages were 52.0 and 78.0%, respectively. The positive rate of cyclin D1 increased with later pathological stage. The expression of advanced laryngeal SCC was higher than that of early-stage laryngeal SCC (Z=−3.182, P\<0.05). The proportions of positive staining of the lymph-metastasis and non-lymph-metastasis groups were 82.1 and 54.5%, respectively; the expression difference was statistically significant (Z=−4.211, P\<0.05). The proportions of positive staining of the smoking and non-smoking groups were 70.6 and 47.9%, respectively; the expression difference was statistically significant (Z=−2.518, P\<0.05).

The expression of cyclin D1 was not significantly associated with gender, age, primary tumor site or drinking habits ([Table IV](#t4-etm-06-05-1137){ref-type="table"}).

Correlation analysis of Ang-2 and cyclin D1 expression in laryngeal SCC
-----------------------------------------------------------------------

In this study, all cases were stained for cyclin D1 and Ang-2 simultaneously. There were 28 cases negative for both and 48 cases positive for both Ang-2 and cyclin D1. Spearman's rank correlation analysis results demonstrated a positive correlation between cyclin D1 and Ang-2 expression in laryngeal SCC (r=0.5042; P\<0.05; [Table V](#t5-etm-06-05-1137){ref-type="table"}).

One-way analysis of clinically pathological parameters and laryngeal SCC patient survival time
----------------------------------------------------------------------------------------------

Using log-rank one-way analysis, we demonstrated that laryngeal SCC prognosis is associated with smoking, TNM stage, lymph metastasis, tumor classification, tumor location, cyclin D1 and Ang-2, but is not correlated with age, gender or drinking habit ([Table VI](#t6-etm-06-05-1137){ref-type="table"}).

Survival analysis
-----------------

Using multi-factor Cox proportional hazards regression models to analyze TNM stage, lymph metastasis, tumor classification, tumor location, cyclin D1 and Ang-2, the tumor classification and cyclinD1 are associated with the survival rate ([Figs. 9](#f9-etm-06-05-1137){ref-type="fig"} and [10](#f10-etm-06-05-1137){ref-type="fig"}). The survival rate of well differentiated, moderately differentiated and poorly differentiated groups was 78.3, 66.7 and 0.91%, respectively. The survival rate of of cyclin D1 −/+/++/+++ groups was 88.9, 76.5, 42.9 and 25.0%, respectively. The tumor classification and cyclin D1 each were able to act as independent prognostic factors.

Discussion
==========

Similar to the majority of solid tumors, laryngeal SCC induction and development is subject to various factors, including modulation of tumor angiogenesis and the cell cycle. As a member of the angiopoietins, Ang-2 exerts a regulatory effect on angiogenesis ([@b7-etm-06-05-1137]). Cyclin D1 is classified as an oncogene. Once cyclin D1 mutates or expresses excessively during the process of cell proliferation, cyclin D1 promotes the induction and development of a tumor ([@b8-etm-06-05-1137]).

The Ang-2 protein is composed of 496 amino-acids with a molecular weight of 70 kDa, the gene for which is located at chromosome 8p23.1. The protein comprises a signal peptide, amino-end α-spiral hinge and carboxy-end fibrous protein sample regions ([@b9-etm-06-05-1137]). Ang-2 mainly exists in the form of a homodimer and is able to combine with vascular endothelium Tie-2 without causing phosphorylation of the receptor. However, Ang-2 is able to competitively block the effect of Ang-1, relax endothelial cells and perivascular sertoli cells, and accelerate vascular bed degeneration and extravascular substrate degradation, which renders the vascular net unstable, thus providing favorable conditions for endothelial cell division and new blood vessel reconstruction ([@b7-etm-06-05-1137]).

The study by Yan *et al* ([@b10-etm-06-05-1137]) on 64 cases of colorectal cancer has observed that, as the differentiation decreases, the expression rate of Ang-2 increases, which indicates that Ang-2 propelled the deterioration of the tumor. A study by Chen *et al* ([@b11-etm-06-05-1137]) on 51 cases of hepatocellular carcinoma suggested that Ang-2 is a marker of hepatocellular carcinoma. Research by Wang *et al* ([@b12-etm-06-05-1137]) on 50 cases of cervical cancer has demonstrated that as the differentiation decreases, the expression rate of Ang-2 tended to increase. In addition, the microvessel density rose markedly, which indicated the involvement of Ang-2 in hepatocellular carcinoma development ([@b13-etm-06-05-1137]). A study of 335 cases of non-small cell lung cancer by Anderson *et al* ([@b14-etm-06-05-1137]) studied the correlation between the expression of Ang-2 and prognosis, which showed that Ang-2 was a signal of tumor prognosis. Hashizume *et al* ([@b15-etm-06-05-1137]) suggest that Ang-2 may slow down the growth of tumors and therefore accelerate tumor cell death.

The results of the present study demonstrated that Ang-2 expression in laryngeal SCC specimens was markedly higher than that in atypical hyperplasia and vocal cord polyp tissues (P\<0.05). Ang-2 was mainly located in the cytoplasm of laryngeal SCC cells. Therefore, we suggest that tumor cells generate Ang-2, which functions through autocrine and paracrine systems. Ang-2 expression in cancer tissues was markedly higher than that in normal laryngeal mucosal tissues. As the differentiation decreased, the expression of Ang-2 increased. We hypothesize that Ang-2 induces the split and shift of endothelial cells, permitting new vessels to grow by budding to promote the occurrence and development of a tumor. This study also showed that as the clinical stage advanced, Ang-2 expression increased. The expression of Ang-2 in the moderately and poorly differentiated groups was higher than that in the well differentiated group. Expression was higher in the lymph-metastasis group than in the non-lymph-metastasis group, which indicates that Ang-2 may promote laryngeal SCC infiltration and lymph metastasis.

Cyclin D1, the key protein of the G1 stage during cell proliferation, may interact with multiple proteins and transition the cell into the S stage. Therefore, it is considered a significantly positive regulator in the G1/S transition in the cell cycle ([@b16-etm-06-05-1137]). When the level of cyclin D1 increases, the G1/S stage shortens, with cell proliferation and canceration. There are various ways for the cyclin D1 gene to mutate within tumors, including gene amplification, chromosome translocation and inversion, among them gene amplification is the most common. In a study by Marsit *et al* ([@b17-etm-06-05-1137]), 698 cases of head and neck SCC underwent immunohistochemical testing. The results showed that, cyclin D1 was expressed in head and neck SCC tissues. Cyclin D1 was highly expressed in T3+T4 stages, but was rare in T1+T2. This indicates that cyclin D1 is relevant to tumor stage and may be regarded as a potential prognostic signal of head and neck SCC.

Our results have demonstrated that the expression of cyclin D1 in laryngeal SCC tissues is markedly higher than that in atypical hyperplasia and vocal cord polyp tissues (P\<0.05). As the differentiation decreased, the expression of cyclin D1 increased, which indicated that the upregulated expression of cyclin D1 was associated with the degree of malignancy of laryngeal SCC. Solid tumor growth, proliferation and metastasis require new vessel support. At present, there are few studies concerning the correlation of cyclin D1 and Ang-2 expression with tumors. The present study showed that positive correlation exists between cyclin D1 and Ang-2 expression in laryngeal SCC, which indicates that both exert a synergic effect on laryngeal SCC occurrence, development and metastasis. We conducted analysis of 116 laryngeal SCC patients through log-rank one-way method and observed that laryngeal SCC prognosis is associated with smoking, TNM stage, lymph metastasis, tumor classification, tumor location, cyclin D1 and Ang-2, and is not associated with age, gender or drinking habit ([Table 6](#t6-etm-06-05-1137){ref-type="table"}). Using multi-factor Cox proportional hazards regression models to analyze TNM stage, lymph metastasis, tumor classification, tumor location, cyclin D1 and Ang-2, it was demonstrated that the tumor classification and cyclin D1 are associated with the survival rate ([Figs. 9](#f9-etm-06-05-1137){ref-type="fig"} and [10](#f10-etm-06-05-1137){ref-type="fig"}). The tumor classification and cyclin D1 were able to act as independent prognostic factors. Log-rank one-way method and multi-factor Cox proportional hazards regression models for tumor classification identified cyclin D1 as the independent factor affecting patient survival time ([Figs. 9](#f9-etm-06-05-1137){ref-type="fig"} and [10](#f10-etm-06-05-1137){ref-type="fig"}). Furthermore, this study did not observe any association between cyclin D1 expression and patient gender, age or drinking habit.

![Expression of Ang-2 in well differentiated laryngeal SCC: the cytoplasm of tumor cells presents bright yellow (magnification ×400). Ang-2, angiopoietin-2; SCC, squamous cell carcinoma.](ETM-06-05-1137-g00){#f1-etm-06-05-1137}

![Expression of Ang-2 in moderately differentiated laryngeal SCC: the cytoplasm of tumor cells presents as brown yellow (magnification ×400). Ang-2, angiopoietin-2; SCC, squamous cell carcinoma.](ETM-06-05-1137-g01){#f2-etm-06-05-1137}

![Expression of Ang-2 in poorly differentiated laryngeal SCC: the cytoplasm of tumor cells presents as brown (magnification ×400). Ang-2, angiopoietin-2; SCC, squamous cell carcinoma.](ETM-06-05-1137-g02){#f3-etm-06-05-1137}

![Expression of Ang-2 in moderately differentiated laryngeal SCC: the cytoplasm of tumor cells presents as brown yellow while the vascular endothelial cells are brown (magnification ×400). Ang-2, angiopoietin-2; SCC, squamous cell carcinoma.](ETM-06-05-1137-g03){#f4-etm-06-05-1137}

![Expression of cyclin D1 in well differentiated laryngeal SCC: the nucleus of tumor cells presents as bright yellow (magnification ×400). SCC, squamous cell carcinoma.](ETM-06-05-1137-g04){#f5-etm-06-05-1137}

![Expression of cyclin D1 in moderately differentiated laryngeal SCC: the nucleus of tumor cells presents as brown yellow (magnification ×400). SCC, squamous cell carcinoma.](ETM-06-05-1137-g05){#f6-etm-06-05-1137}

![Expression of cyclin D1 in poorly differentiated laryngeal SCC: the nucleus of tumor cells suffuses as brown (magnification ×400). SCC, squamous cell carcinoma.](ETM-06-05-1137-g06){#f7-etm-06-05-1137}

![Expression of cyclin D1 in the tumor cell infiltrating into lymph gland: the nucleus of tumor cells presents as brown (magnification ×400).](ETM-06-05-1137-g07){#f8-etm-06-05-1137}

![Survival rate of patients with laryngeal SCC in the well, moderately and poorly differentiated groups. SCC, squamous cell carcinoma.](ETM-06-05-1137-g08){#f9-etm-06-05-1137}

![Survival rate of patients in cyclin D1-/+/++/+++ groups.](ETM-06-05-1137-g09){#f10-etm-06-05-1137}

###### 

Ang-2 expression in vocal cord polyp, atypical hyperplasia and laryngeal SCC tissues.

  Histopathological type        n    Ang-2 expression        
  ----------------------------- ---- ------------------ ---- -------
  Vocal cord polyp              5    5                  0    0.0
  Atypical hyperplasia          5    5                  0    0.0
  Laryngeal SCC                                              
    Well differentiated         60   36                 24   40.0
    Moderately differentiated   45   15                 30   66.7
    Poorly differentiated       11   0                  11   100.0

Ang-2, angiopoietin-2; SCC, squamous cell carcinoma.

###### 

Cyclin D1 expression in vocal cord polyp, atypical hyperplasia and laryngeal SCC tissues.

  Histopathological type        n    Cyclin D1 expression        
  ----------------------------- ---- ---------------------- ---- -------
  Vocal cord polyp              5    5                      0    0.0
  Atypical hyperplasia          5    5                      0    0.0
  Laryngeal SCC                                                  
    Well differentiated         60   30                     30   50.0
    Moderately differentiated   45   15                     30   66.7
    Poorly differentiated       11   0                      11   100.0

SCC, squamous cell carcinoma.

###### 

Expression of Ang-2 and clinicopathologic characteristics of the patients with laryngeal SCC.

  Characteristics         n     Ang-2 expression   Z    P-value                 
  ----------------------- ----- ------------------ ---- --------- ---- -------- --------
  Gender                                                                        
    Male                  107   47                 22   20        18   −0.038   0.9695
    Female                9     4                  2    1         2             
  Age (years)                                                                   
    ≤60                   43    18                 10   8         7    0.127    0.8990
    \>60                  73    33                 14   13        13            
  Smoking                                                                       
    Yes                   68    22                 16   13        17   −3.190   0.0014
    No                    48    29                 8    8         3             
  Drinking                                                                      
    Yes                   49    26                 8    7         8    1.350    0.1771
    No                    67    25                 16   14        12            
  TNM staging                                                                   
    T1+T2                 75    40                 16   9         10   −3.006   0.0026
    T3+T4                 41    11                 8    12        10            
  Lymph node metastasis                                                         
    Yes                   28    5                  5    7         11   −4.129   0.0000
    No                    88    46                 19   14        9             
  Tumor differentiation                                                         
    Well                  60    36                 14   5         5    −3.258   0.0011
    Moderately            45    15                 8    12        10   −4.360   0.0000
    Poorly                11    0                  2    4         5    −2.274   0.0230
  Primary tumor site                                                            
    Supraglottic          28    12                 7    2         7    0.860    0.390
    Glottic               73    36                 11   14        12            
    Subglottic            15    3                  6    5         1             

Ang-2, angiopoietin-2; SCC, squamous cell carcinoma.

###### 

Expression of cyclin D1 and clinicopathologic characteristics of the patients with laryngeal SCC.

  Characteristics         \(n\)   cyclin D1 expression   Z    P-value                 
  ----------------------- ------- ---------------------- ---- --------- ---- -------- --------
  Gender                                                                              
    Male                  107     42                     33   17        15   −0.796   0.4260
    Female                9       3                      1    4         1             
  Age (years)                                                                         
    ≤60                   43      15                     10   11        7    −0.045   0.9641
    \>60                  73      30                     19   11        13            
  Smoking                                                                             
    Yes                   68      20                     21   16        11   −2.518   0.0118
    No                    48      25                     13   5         5             
  Drinking                                                                            
    Yes                   49      18                     17   6         8    −0.106   0.9159
    No                    67      27                     17   15        8             
  TNM staging                                                                         
    T1+T2                 75      36                     22   10        7    −3.182   0.0015
    T3+T4                 41      9                      12   11        9             
  Lymph node metastasis                                                               
    Yes                   28      5                      5    9         9    −4.211   0.0000
    No                    88      40                     29   12        7             
  Tumor differentiation                                                               
    Well                  60      30                     22   4         4    −2.814   0.0049
    Moderately            45      15                     9    13        8    −4.087   0.0000
    Poorly                11      0                      3    4         4    −2.071   0.0384
  Primary tumor site                                                                  
    Supraglottic          28      8                      9    6         5    0.460    0.640
    Glottic               73      33                     21   13        6             
    Subglottic            15      4                      4    2         5             

SCC, squamous cell carcinoma.

###### 

Correlation analysis of Ang-2 and cyclin D1 expression in laryngeal SCC.

  Cyclin D1 expression   n     Ang-2 expression             
  ---------------------- ----- ------------------ ---- ---- ----
  −                      45    28                 8    8    1
  \+                     34    18                 10   4    2
  ++                     21    4                  4    5    8
  +++                    16    1                  2    4    9
  Total                  116   51                 24   21   20

Ang-2, angiopoietin-2; SCC, squamous cell carcinoma.

###### 

One-way analysis of clinically pathological parameters and laryngeal SCC patient survival time.

  Parameter               Group                             χ^2^     P-value
  ----------------------- --------------------------------- -------- ---------
  Gender                  Male/female                       0.005    0.945
  Age (years)             ≤60/\>60                          2.072    0.150
  Smoking                 Yes/no                            4.598    0.032
  Drinking                Yes/no                            0.333    0.564
  TNM staging             T1+T2/T3+T4                       6.026    0.014
  Lymph node metastasis   Yes/no                            16.744   0.000
  Tumor differentiation   Well/moderately/poorly            34.527   0.000
  Primary tumor site      Supraglottic/glottic/subglottic   8.456    0.015
  Cyclin D1               (−)/(+)/(++)/(+++)                42.220   0.000
  Ang-2                   (−)/(+)/(++)/(+++)                22.393   0.000

SCC, squamous cell carcinoma.

[^1]: Contributed equally
